Skip to main content
. 2020 Jul 7;12(1):e12054. doi: 10.1002/dad2.12054

TABLE 1.

Baseline characteristics of study participants from the Gingko Evaluation of Memory (GEM) Study (2000‐2008) by number of sensory impairments

Characteristic n (%) or mean (SD) No sensory impairment (n = 1480) Single sensory impairment (n = 467) Dual sensory impairment (n = 104)
Age (years)a, mean (SD) 78.4 (3.1) 78.5 (3.2) 79.1 (3.5)
Sex
Female 653 (44.1) 218 (46.7) 34 (32.7)
Male 827 (55.9) 249 (53.3) 70 (67.3)
Race
White 1,438 (97.2) 451 (96.6) 100 (96.1)
Non‐white 42 (2.8) 16 (3.4) 4 (3.9)
Education (years), mean (SD) 14.6 (3.1) 14.3 (3.4) 14.0 (3.2)
Body mass indexb, mean (SD) 27.1 (4.2) 27.3 (4.2) 27.1 (4.1)
Cardiovascular diseasec 317 (21.5) 105 (22.5) 26 (25.0)
Cerebrovascular diseased 112 (7.6) 48 (9.2) 11 (10.6)
Diabetes 134 (9.1) 43 (9.2) 13 (12.5)
Hypertensione 804 (54.3) 241 (51.2) 58 (55.8)
Smoking status
Current smoker 71 (4.8) 16 (3.4) 5 (4.8)
Former smoker 813 (54.9) 276 (59.1) 61 (58.7)
Never smoker 596 (40.3) 175 (37.5) 38 (36.5)
Drinks per week, mean (SD) 3.7 (6.7) 3.5 (6.6) 5.0 (8.0)
Blocks/miles walked per week, mean (SD) 7.3 (8.6) 7.8 (10.0) 6.9 (7.9)
3MSE scoref, mean (SD) 93.6 (4.6) 93.0 (4.7) 91.9 (4.7)
APOE ε4g
≥1 ε4 allele 356 (24.1) 109 (23.3) 23 (22.1)
No ε4 allele 1,124 (75.9) 358 (76.7) 81 (77.9)
Treatment status
G. biloba 747 (50.5) 233 (49.9) 53 (51.0)
Placebo 733 (49.5) 234 (50.1) 51 (49.0)
a

Age = age at randomization.

b

Body mass index = kg/m2.

c

Cardiovascular disease = self‐reported history of the following conditions (heart attack, angina, heart failure, coronary bypass surgery, balloon angioplasty).

d

Cerebrovascular disease = self‐reported history of stroke, or transient ischemic attack/small stroke.

e

Hypertension = blood pressure >140/90, or use of anti‐hypertensives.

f

3MSE score = Modified Mini‐Mental State Examination.

g

APOE ε4 = apolipoprotein E ε4 allele.